Nadira Muthi Tsania, - and Maftuchah Rochmanti, - and Lukman Hakim, - and Mochammad Thaha, - (2020) A Potential Combination Of HDL-Cholesterol And Hs-CRP For Inflammation Monitoring In CKD Patient With Statin Therapy. Sapporo Medical Journal, 54 (10). pp. 1-9. ISSN 0036-472X

	Text (Artikel) A Potential Combination of HDL-Cholesterol and HS-CRP for Inflammation Monitoring in CKD Patient with Statin Therapy.pdf Download (181kB)
	Text (Peer Review) A Potential Combination.pdf Download (1MB)
	Text (Similarity) A Potential Combination of HDL-Cholesterol and HS-CRP for Inflammation Monitoring in CKD Patient with Statin Therapy.pdf Download (2MB)
	Text (Bukti Korespondensi) 3. Email acceptance_Maftuchah with Nadira Muthi Ts_SMJ.pdf Download (209kB)
	Text (Peer Review) 5.pdf Download (1MB)
	Text (Artikel) Artikel 5.pdf Download (2MB)

Abstract

Reducing inflammation can be one of the therapeutic targets in in Chronic Kidney Disease (CKD) patients. Many studies have shown that statins have pleiotropic effects as anti-inflammation. In this study we will be seen interaction of HDL-Cholesterol and hs-CRP to prove the role of statins as an anti-inflammatory and dyslipidemia treatment simultaneously. We compared hs-CRP and HDL Cholesterol/hs-CRP ratio levels in CKD patients who took statins and who did not take statins. Forty samples of CKD patients were taken randomly and then grouped based on their consumption of statin: taking statins (20) and not taking statins (20). There were negative correlation between HDL Cholesterol and hs-CRP (R=-0.374; P= 0.017), positive correlation between HDL Cholesterol/hs-CRP ratio and eGFR (R= 0.421; P= 0.007). The median concentration of hs-CRP in the statin group was significantly lower than in non-statin group (1.80 (1.20 – 5.30) vs 3.60 (1.90 – 11.60); P= 0.038), meanwhile there were not significantly different of median of HDL Cholesterol and HDL Cholesterol/hs-CRP Ratio between group. CKD subjects that consumed statin have a lower hs-CRP compared to subject that did not consume statin. But there was no difference of HDL-Cholesterol/hs-CRP ratio between CKD subjects that consume statin compared to did not consume statin but had a good correlation with eGFR. This result mean that HDL-Cholesterol and hs-CRP monitoring very important in CKD patient with statin treatment.

Actions (login required)

View Item